Dimensional Fund Advisors LP decreased its position in MediciNova, Inc. (NASDAQ:MNOV) by 8.0% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 88,314 shares of the biopharmaceutical company’s stock after selling 7,660 shares during the period. Dimensional Fund Advisors LP owned 0.25% of MediciNova worth $465,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of MNOV. Northern Trust Corp increased its stake in MediciNova by 10.6% in the 2nd quarter. Northern Trust Corp now owns 368,599 shares of the biopharmaceutical company’s stock valued at $1,939,000 after buying an additional 35,331 shares during the last quarter. SG Americas Securities LLC increased its stake in MediciNova by 88.9% in the 2nd quarter. SG Americas Securities LLC now owns 61,930 shares of the biopharmaceutical company’s stock valued at $326,000 after buying an additional 29,153 shares during the last quarter. State of Wisconsin Investment Board purchased a new stake in MediciNova in the 2nd quarter valued at about $137,000. Vanguard Group Inc. increased its stake in MediciNova by 1.0% in the 2nd quarter. Vanguard Group Inc. now owns 1,197,716 shares of the biopharmaceutical company’s stock valued at $6,300,000 after buying an additional 12,249 shares during the last quarter. Finally, TIAA CREF Investment Management LLC increased its stake in MediciNova by 7.2% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 90,295 shares of the biopharmaceutical company’s stock valued at $475,000 after buying an additional 6,035 shares during the last quarter. Hedge funds and other institutional investors own 21.93% of the company’s stock.

Shares of MediciNova, Inc. (NASDAQ:MNOV) opened at $6.52 on Wednesday. MediciNova, Inc. has a one year low of $4.40 and a one year high of $7.85.

WARNING: This report was posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this report on another website, it was stolen and republished in violation of international copyright and trademark legislation. The correct version of this report can be accessed at https://theolympiareport.com/2017/12/06/dimensional-fund-advisors-lp-has-465000-holdings-in-medicinova-inc-mnov.html.

About MediciNova

Medicinova, Inc is a biopharmaceutical company. The Company focuses on acquiring and developing small molecule therapeutics for the treatment of diseases with unmet medical needs and a commercial focus on the United States market. Its pipeline includes MN-166 (ibudilast), MN-001 (tipelukast), MN-221 (bedoradrine) and MN-029 (denibulin).

Want to see what other hedge funds are holding MNOV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MediciNova, Inc. (NASDAQ:MNOV).

Institutional Ownership by Quarter for MediciNova (NASDAQ:MNOV)

Receive News & Ratings for MediciNova Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediciNova Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.